# Innate Pharma to hold its annual general meeting of shareholders on May 21, 2026
Canonical URL: https://biopharmsignal.com/news/IPHA/innate-pharma-to-hold-its-annual-general-meeting-of-shareholders-on-may-21-2026
Ticker: IPHA
Company: Innate Pharma
Source: Innate Pharma
Published: 2026-04-10 15:39 EST
Original Source URL: https://www.innate-pharma.com
## Summary

<span>L’assemblée générale d’Innate Pharma aura lieu le 21 mai 2026</span> <div class="field field--name-field-date-from field--type-datetime field--label-hidden field--item"><i class="fa fa-clock-o" aria-hidden="true"></i> <time datetime="2026-04-13T05:00:00Z">lun, 04/13/2026 - 07:00</time> </div> <div class="field fi

## Article Body
L’assemblée générale d’Innate Pharma aura lieu  le 21 mai 2026

lun, 04/13/2026 - 07:00

Press release in English
                      119.05 Ko
                  
                      
                      Communiqué de presse en français
                      121.66 Ko

helene

ven, 04/10/2026 - 17:50
## Recent Company News
- 2026-07-22 11:17 EST — [Innate Pharma to participate in a bladder cancer panel at the BTIG Virtual Biotechnology Conference](https://biopharmsignal.com/news/IPHA/innate-pharma-to-participate-in-a-bladder-cancer-panel-at-the-btig-virtual-biote-960627c0) — Source: Innate Pharma
- 2026-07-20 14:53 EST — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f) — Source: Innate Pharma
- 2026-05-21 17:08 EST — [Outcome of Innate Pharma’s 2026 Annual General Meeting](https://biopharmsignal.com/news/IPHA/outcome-of-innate-pharma-s-2026-annual-general-meeting) — Source: Innate Pharma
- 2026-05-18 11:27 EST — [Innate Pharma to participate in the Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/IPHA/innate-pharma-to-participate-in-the-jefferies-global-healthcare-conference) — Source: Innate Pharma
- 2026-05-12 13:48 EST — [Innate Pharma Reports First Quarter 2026 Business Update and Financial Results](https://biopharmsignal.com/news/IPHA/innate-pharma-reports-first-quarter-2026-business-update-and-financial-results) — Source: Innate Pharma
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
